Glenmark Pharmaceuticals Limited — Salbutamol Exporter Profile
Indian Pharmaceutical Exporter · #2 for Salbutamol · $5.7M export value · DGFT Verified
Glenmark Pharmaceuticals Limited is the #2 Indian exporter of Salbutamol with $5.7M in export value and 298 verified shipments. Glenmark Pharmaceuticals Limited holds a 3.9% market share in Salbutamol exports across 11 countries. The company exports 28 pharmaceutical products worth $205.5M across 14 therapeutic categories.
Glenmark Pharmaceuticals Limited — Salbutamol Export Profile: Buyers & Destinations
Where Does Glenmark Pharmaceuticals Limited Export Salbutamol?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BRAZIL | $3.3M | 257 | 86.5% |
| UZBEKISTAN | $151.9K | 17 | 4.0% |
| PHILIPPINES | $137.4K | 3 | 3.6% |
| KAZAKHSTAN | $116.7K | 11 | 3.0% |
| CAMBODIA | $94.1K | 4 | 2.5% |
| FIJI | $10.5K | 2 | 0.3% |
| POLAND | $4.4K | 3 | 0.1% |
| SOUTH AFRICA | $3.8K | 1 | 0.1% |
| BARBADOS | $373 | 1 | 0.0% |
| DOMINICAN REPUBLIC | $12 | 1 | 0.0% |
Glenmark Pharmaceuticals Limited exports Salbutamol to 11 countries. The largest destination is BRAZIL accounting for 86.5% of Glenmark Pharmaceuticals Limited's Salbutamol shipments, followed by UZBEKISTAN (4.0%) and PHILIPPINES (3.6%). These destinations reflect Glenmark Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Salbutamol from Glenmark Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| GLENMARK FARMACEUTICA LTDA. | BRAZIL | $1.3M | 40 |
| GLENMARK FARMACEUTICA LTDA | BRAZIL | $875.3K | 20 |
| GLENMARK FARMAC?UTICA LTDA. | BRAZIL | $302.9K | 59 |
| GLENMARK FARMAC?UTICA LTDA., | BRAZIL | $233.8K | 8 |
| GLENMARK FARMACUTICA LTDA, | BRAZIL | $205.0K | 69 |
| GLENMARK PHILIPPINES INC | PHILIPPINES | $137.4K | 3 |
| GLENMARK FARMACUTICA LTDA. | BRAZIL | $119.4K | 16 |
| DKSH (CAMBODIA) LTD | CAMBODIA | $94.1K | 4 |
| LLC NOVOTEK | UZBEKISTAN | $82.1K | 4 |
| GLENMARK FARMACUTICA LIMITEDA | BRAZIL | $71.8K | 20 |
Glenmark Pharmaceuticals Limited supplies Salbutamol to 32 buyers globally. The largest buyer is GLENMARK FARMACEUTICA LTDA. (BRAZIL), followed by GLENMARK FARMACEUTICA LTDA (BRAZIL) and GLENMARK FARMAC?UTICA LTDA. (BRAZIL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Salbutamol Export Value and How Much Does Glenmark Pharmaceuticals Limited Contribute?
India exported $130.8M worth of Salbutamol through 14,359 shipments from 602 suppliers to 164 countries, serving 1,775 buyers globally. Glenmark Pharmaceuticals Limited contributes $5.7M to this total, accounting for 3.9% of India's Salbutamol exports. Glenmark Pharmaceuticals Limited ships Salbutamol to 11 countries through 32 buyers.
What Is the Average Shipment Value for Glenmark Pharmaceuticals Limited's Salbutamol Exports?
Glenmark Pharmaceuticals Limited's average Salbutamol shipment value is $19.3K per consignment, based on 298 shipments totaling $5.7M. The largest destination is BRAZIL (86.5% of Glenmark Pharmaceuticals Limited's Salbutamol exports).
How Does Glenmark Pharmaceuticals Limited Compare to Other Indian Salbutamol Exporters?
Glenmark Pharmaceuticals Limited ranks #2 among 602 Indian Salbutamol exporters with a 3.9% market share. The top 3 exporters are CIPLA LIMITED ($100.3M), GLENMARK PHARMACEUTICALS LIMITED ($5.7M), AHLCON PARENTERALS (INDIA) LIMITED ($4.9M). Glenmark Pharmaceuticals Limited processed 298 shipments to 11 destination countries.
What Salbutamol Formulations Does Glenmark Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| Salbutamol 100mcg 200MDI | $1.5M | 62 |
| SALBUTAMOL 100MCG 200MDI | $799.5K | 74 |
| SALBUTAMOL 100MCG 200MDINOS | $168.9K | 30 |
| Salbutamol 100mcg 200MDI Salbutamol Pressurised Inhalation BP 100 mcg actuation | $50.0K | 1 |
| Salbutamol 100mcg 200MDI. Batch no.14230 | $50.0K | 1 |
| PECOF TABLETS 10X1X10' S (SALBUTAMOL SULPHATE, BROMHEXINE HCL,GUAIFENESIN TABLETS) (QTY: 9,662 CAR) | $50.0K | 1 |
| ASCORIL TABLETS 2X10'S (Salbutamol Sulphate, Bromhexine Hcl, Guaifenesin Tablets) (QTY: 30,000 CAR) | $50.0K | 1 |
| PECOF TABLETS 10X1X10' S (Salbutamol Sulphate, Bromhexine Hcl, Guaifenesin Tablets) (QTY: 4,776 CAR) | $44.5K | 1 |
| ASCORIL EXPECTORANT 100ML (Salbutamol Sulphate, Bromhexine Hcl, and GuaifenesinSyrup) (QTY: 6,480 BOT) | $44.1K | 2 |
| PECOF TABLETS 10X1X10 S Salbutamol Sulphate Bromhexine Hcl Guaifenesin Tablets QTY 4 758 CAR | $43.0K | 1 |
Glenmark Pharmaceuticals Limited exports 122 distinct Salbutamol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Salbutamol 100mcg 200MDI with 62 shipments worth $1.5M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Salbutamol to Key Markets
What Glenmark Pharmaceuticals Limited must comply with to export Salbutamol to its top destination countries
Brazil — ANVISA
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Glenmark Pharmaceuticals Limited Compare to Nearest Salbutamol Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | CIPLA LIMITED | $100.3M | 2,828 | 41 | $35.5K |
| 2 | GLENMARK PHARMACEUTICALS LIMITED ★ | $5.7M | 298 | 11 | $19.3K |
| 3 | AHLCON PARENTERALS (INDIA) LIMITED | $4.9M | 117 | 4 | $42.1K |
| 4 | MEDISPRAY LABORATORIES PRIVATE LIMITED | $4.9M | 177 | 2 | $27.5K |
Glenmark Pharmaceuticals Limited ranks #2 among 602 Indian Salbutamol exporters. Average shipment value of $19.3K compared to the market average of $217.4K. The closest competitors by value are CIPLA LIMITED and AHLCON PARENTERALS (INDIA) LIMITED.
Which Indian Ports Ship Salbutamol Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 2,198 | 15.3% |
| SAHAR AIR | 2,141 | 14.9% |
| DELHI AIR CARGO ACC (INDEL4) | 1,530 | 10.7% |
| NHAVA SHEVA SEA (INNSA1) | 1,497 | 10.4% |
| DELHI AIR | 1,064 | 7.4% |
| JNPT/ NHAVA SHEVA SEA | 1,036 | 7.2% |
| JNPT | 842 | 5.9% |
| Bombay Air | 568 | 4.0% |
What Other Respiratory Products Does Glenmark Pharmaceuticals Limited Export?
Glenmark Pharmaceuticals Limited also exports these respiratory products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Glenmark Pharmaceuticals Limited's Salbutamol Exports
Glenmark's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, causing increased freight costs and extended transit times. These challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management. (pharmaceuticalcommerce.com)
Conversely, the US-China trade tensions have opened avenues for Indian pharmaceutical companies like Glenmark to expand their footprint in the US market. The shifting trade dynamics have prompted US importers to seek alternative suppliers, presenting growth opportunities for Indian exporters.
The recent India-European Union Free Trade Agreement (FTA) is poised to benefit Glenmark by eliminating tariffs on pharmaceutical exports to the EU. This development enhances the company's competitiveness in the European market, potentially boosting export volumes and revenue streams. (en.wikipedia.org)
Glenmark Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Glenmark's export success. The company has consistently adhered to guidelines set by the US FDA, WHO, and EU GMP, ensuring the quality and safety of its products. Notably, Glenmark's manufacturing facilities have undergone rigorous inspections, reflecting its commitment to maintaining high-quality standards.
The evolving regulatory landscape, including the EU's Falsified Medicines Directive, necessitates continuous adaptation. Glenmark's proactive approach to compliance positions it well to navigate these changes, thereby sustaining its market access and reputation.
About Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited exports 28 products worth $205.5M. Beyond Salbutamol, top products include Rosuvastatin, Omeprazole, Gabapentin, Ondansetron, Naproxen. View the complete Glenmark Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Salbutamol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Salbutamol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Glenmark Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 301 individual customs records matching Glenmark Pharmaceuticals Limited exporting Salbutamol, covering 122 formulations to 11 countries via 32 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 164+ countries, 1,775+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Salbutamol Export Data from Glenmark Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Glenmark Pharmaceuticals Limited's Salbutamol exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Glenmark Pharmaceuticals Limited
Full Company Profile →
28 products · $205.5M total trade · 14 categories
Salbutamol Stats
Company Overview
Top Products by Glenmark Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Glenmark Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Salbutamol. For current shipment-level data, contact TransData Nexus.